Nazarbayev University
15
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
20%
3 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity
Role: lead
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Role: lead
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Role: collaborator
Low-Load Blood Flow Restriction Training vs Traditional Resistance Training Exercises Following ACLR Surgery
Role: collaborator
Cervical Cancer Screening Via Self-sampling
Role: lead
Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS
Role: lead
Ventriculo-Arterial Coupling and Intra-Dialytic Changes in Hemodialysis Patients: Prognostic Insights
Role: lead
The Gut Microbiome in Chronic Heart Failure
Role: lead
Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan
Role: lead
Immunological Profile and Microbial Markers in Evaluating the Effectiveness of Probiotic Therapy in RA Patients
Role: lead
Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer
Role: lead
Non-invasive Assessment of Mechano-chemical Properties of Urine Proteins by Hybrid Brillouin-Raman Spectroscopy
Role: lead
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Role: lead
Functional Reserve Estimation of Donor Kidney
Role: lead
Physical and Chemical Study of Atherosclerosis Mechanisms
Role: lead
All 15 trials loaded